Development
Ekso Bionics Holdings, Inc.
EKSO
$3.14
-$0.11-3.39%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -1.13% | 21.82% | -42.04% | 5.00% | -11.00% |
| Total Depreciation and Amortization | 161.63% | 104.79% | 15.58% | 79.22% | 7.05% |
| Total Amortization of Deferred Charges | -8,000.00% | 8,100.00% | 7,950.00% | -- | -- |
| Total Other Non-Cash Items | 178.45% | -24.14% | 49.12% | -63.99% | 51.21% |
| Change in Net Operating Assets | 354.60% | -478.22% | 121.08% | 21.93% | -224.22% |
| Cash from Operations | 56.53% | -29.46% | 31.66% | -0.19% | -18.50% |
| Capital Expenditure | 18.87% | 87.94% | -- | -- | -5,400.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 99.15% | 87.94% | -- | -- | -503,500.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -186.96% | 100.00% | 25.00% | 133.33% | -43.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.99% | -23.35% | 30.35% | -0.43% | -185.36% |